|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Induction chemotherapy with cisplatin and fluomuracil alone or in combination with do- cetaxel in locally advanced squamous-cell cancer of the head and neck : long - term results of the TAX 324 randomised phase 3 trial 显示文摘 | Lorch JH Goloubeva O Haddad RI | 2011 | The Lancet Oncology2011，12，2： | 1 |
| 2 | Characterization of a porcine lung epithelial cell line suitable for influenza virus studies 显示文摘 | Seo SH Goloubeva O Webby R | 2001 | J Virol2001，75，19： | 1 |
| 3 | Comparison of efficacies of RWJ-270201,zanamivir,and oseltamivir against H5N1,H9N2,and other avian influenza viruses显示文摘 | Govorkova EA Leneva IA Goloubeva OG | 2001 | Antimicrob Agents Chemother2001，45，10： | 1 |
| 4 | A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma显示文摘 | Bao T Goloubeva O Pelser C | 2014 | Integr Cancer Ther2014，13，5： | 1 |
| 5 | Comparison of efficacies of RWJ-270201,zanamivir,and oseltamivir against H5N1,H9N2,and other avian influenza Viruses显示文摘 | Govorkova EA Leneva IA Goloubeva OG | 2001 | Antimicrob Agents Chemother2001，45，10： | 1 |
| 6 | Divergent effects of castration on prostate cancer in TRAMP mice possible implications for therapy clin 显示文摘 | TANG Yao WANG Lin-bo OLGA GOLOUBEVA | 2008 | Clin Cancer Res2008，14，10： | 1 |
| 7 | Induction chemo- therapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck; long-term results of the TAX324 randomised phase 3 trial显示文摘 | Lorch JH Goloubeva O Haddad RJ | 2011 | Lancet Oncol2011，12，： | 1 |
| 8 | Prevalence and significance of vitamin D deficiency in multiple myeloma patients显示文摘 | Badros A Goloubeva O Terpos E | 2008 | Br J Haematol2008，142，3： | 1 |
| 9 | Neurotoxicity of bortezomib therapy in multiple myeloma:a single-center experience and review of the literature显示文摘 | Badros A goloubeva O Dalal JS | 2007 | Cancer2007，110，5： | 1 |
| 10 | Phase II study of G3139, a Bcl-2 antisense oligonucleotide , in combination with dexamethason and thalidomide in relapsed multiple myeloma patients 显示文摘 | Badros AZ Goloubeva O Rapoport AP etal | 2005 | J Clin Oncol2005，23，18： | 1 |
| 11 | Functional acti- vation of the estrogen receptor-alpha and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole显示文摘 | Sabnis GJ Goloubeva O Chumsri S eta1 | 2011 | Cancer Res2011，，71： | 1 |
| 12 | Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens显示文摘 | Sabnis G Goloubeva O Jelovac D | 2007 | Clin Cancer Res2007，13，9： | 1 |
| 13 | The relationship of neuro-endocrine carcinomas to anti-tumor therapies in TRAMP mice显示文摘 | Tang Y Wang L Goloubeva O | 2009 | Prostate2009，69，16： | 1 |
| 14 | Phase H studyevaluating the addition of cetuximab to the concurrent delivery ofweekly carboplatin,paclitaxel,and daily radiotherapy for patientswith locally advanced squamous cell carcinomas of the head andneck显示文摘 | Suntharalingam M Kwok Y Goloubeva 0 | 2012 | Int J Radiat Oncol Biol Phys2012，82，5： | 1 |
| 15 | Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis显示文摘 | Palmer SL Goloubeva O Reddick WE | 2001 | J Clin Oncoh2001，19，： | 1 |
| 16 | Neurotoxicity of borte- zomib therapy in multiple myeloma: a single- center experi- ence and review of the literature 显示文摘 | Badros A Goloubeva O Dalal JS | 2007 | Cancer2007，110，5： | 1 |
| 17 | Phase Ⅱ study of G3139, a Bcl-2 antisense oligonueleotide, in combination with dexamethason and thalidomide in relapsed multiple myeloma patients显示文摘 | Badros AZ Goloubeva Q Rapoport AP | 2005 | J Clin Oncol2005，23，18： | 1 |
| 18 | Phase Ⅱ study of G3139,a Bcl-2 antisense oligonucleotide,in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients显示文摘 | Badros AZ Goloubeva O Rapoport AP | 2005 | J Clin Oncol2005，23，18： | 1 |
| 19 | Phase Ⅱ study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin,paclitaxel,and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck显示文摘 | Suntharalingam M Kwok Y Goloubeva O | 2012 | Int J Radiat Oncol Biol Phys2012，82，5： | 1 |
| 20 | Preclinical as- sessment of HDAC inhibitor entinostat combined with all trans retinoic acid (ATRA) in aromatase inhibitor resistant breast cmlcer 显示文摘 | Shah P Sabnis G Goloubeva O | 2013 | Cancer Res2013，73，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员